Fundraising Fox

Sean Ainsworth

Investor

Advisory Board - Biotech CEO at FemHealth Ventures

About

Sean Ainsworth is CEO and Chairman of the Board of Immusoft, with over 25 years in biotechnology and pharmaceuticals. He founded and led RetroSense Therapeutics, a gene therapy company sold to Allergan in 2016, and serves as Lead Independent Director at Ocuphire Pharma (Nasdaq: OCUP). He founded Ainsworth BioConsulting in 2004 and holds an MBA from Washington University in St. Louis and a BS in Microbiology from UC San Diego.

LinkedIn ↗

Invests in

Biotech

Investments

Board seats

ImmusoftOcuphire Pharma

Per the firm's website.

Colleagues at FemHealth Ventures

Greg Brown
Healthcare Royalty Investing Pioneer at FemHealth Ventures
Katherine Kalin
Former McKinsey Partner & Pharma Exec at FemHealth Ventures
Maneesha Ghiya
Managing Partner at FemHealth Ventures
Nisha Chakravarty
Wharton Lecturer at FemHealth Ventures
Rache Simmons
Breast Cancer Surgeon at FemHealth Ventures
Randy Cohen
Harvard Business School Professor at FemHealth Ventures
Sara Crown Star
Venture Partner at FemHealth Ventures
Stephan Oppenheimer
Private Equity Investor at FemHealth Ventures